Evaluation on efficacy and safety of capecitabine plus docetaxel versus docetaxel monotherapy in metastatic breast cancer patients pretreated with anthracycline: Results from a randomized phase III study (JO21095)
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 17 Jan 2013
At a glance
- Drugs Capecitabine (Primary) ; Docetaxel
- Indications Advanced breast cancer
- Focus Biomarker; Therapeutic Use
- 17 Jan 2013 New trial record
- 08 Dec 2012 Analysis of the overall survival data is under examination according to the abstract presented at the 35th Annual San Antonio Breast Cancer Symposium.
- 08 Dec 2012 Results of an analysis on the effect of circulating tumour cells on response were presented at the 35th Annual San Antonio Breast Cancer Symposium.